ARQT EBITDA Growth
Arcutis Biotherapeutics Inc · EBITDA Growth
ARQT EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported163.23%period ending
ARQT TTM EBITDA YoY % (-202533.33% → 163.23%)
Year-over-year change
High-resolution chart · PNG
ARQT ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 163.2265% | |
| 114.1069% | |
| 101.7554% | |
| 85.3751% | |
| 58.1066% | |
| 44.3115% | |
| 51.6719% | |
| 30.1607% | |
| 45.9302% | |
| 40.2472% | |
| 22.7261% | |
| 22.1706% | |
| -18.6179% | |
| -31.3986% | |
| -43.2099% | |
| -78.5606% | |
| -70.2571% | |
| -61.7331% | |
| -51.7668% | |
| -47.9432% | |
| -66.0694% | |
| -125.9403% | |
| -219.1409% | |
| -279.0058% | |
| -485.3933% | |
| -820.2895% | |
| -202,533.3333% |